A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer - Bramhall, S R; Schulz, J; Nemunaitis, J (British journal of cancer, 2002)
et al.